Predicting the risk of local recurrence in patients with breast cancer: An approach to a new computer-based predictive tool

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 5, 2007, Pages 473-480

  Sanghani, Mona ^a   Balk, Ethan ^a   Cady, Blake ^b   Wazer, David ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Breast cancer; Computer model; Local recurrence; Predictive model; Radiation

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; LETROZOLE; TAMOXIFEN;

AGE DISTRIBUTION; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ANALYSIS; COMPUTER MODEL; EVIDENCE BASED MEDICINE; HUMAN; INTERNET; LYMPH NODE METASTASIS; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATIENT COUNSELING; PREDICTION; PROGNOSIS; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; FEMALE; HUMANS; INTERNET; MASTECTOMY; META-ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK; RISK FACTORS;

EID: 35148849718     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31805c13d9     Document Type: Article

References (38)

1. Ravdin P, Siminoff L, Davis G, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19:980-991.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
3. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conservation surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997-1003.
4. Renton S, Gazet J, Ford H, et al. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 1996;22:17-22.
5. Clark R, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer: an update. J Natl Cancer Inst. 1996;88:1659-1664.
6. Forrest A, Stewart H, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708-713.
7. Liljegren G, Holmberg L, Bergh J, et al. Ten-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326-2333.
8. Malmstrom P, Holmberg L, Anderson H, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer. 2003;39:1690-1697.
9. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer. 2001;84:164-169.
10. Fisher B, Bryant J, Dignam J, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141-4149.
11. Hughes K, Schnaper L, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971-1023.
12. Fyles A, McCready D, Manchul L, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351:963-970.
13. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-2106.
14. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:115-121.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
16. Voogd A, Nielsen M, Peterse J, et al. Differences in risk factors for local and distant recurrence after breast conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688-1697.
17. Neuschatz A, DiPetrillo T, Safaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer. 2003;97:30-39.
18. Park C, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668-1675.
19. Kunos C, Latson L, Overmoyer B, et al. Breast conservation surgery achieving ->or=2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J. 2006;12:28-36.
20. Cabioglu N, Hunt K, Buchholz T, et al. Improving local control with breast-conserving therapy: a 27-year single institution experience. Cancer. 2005;104:20-29.
21. DiBiase S, Komarnicky L, Heron D, et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phys. 2002;53:680-686.
22. Peterson M, Schultz D, Reynolds C, et al. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 1999;43:1029-1035.
23. Assersohn L, Powles T, Ashley S, et al. Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy, and chemoendocrine therapy. Ann Oncol. 1999;10:1409-1411.
24. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999;15:1005-1015.
25. Spivack B, Khanna M, Tafra L, et al. Margin status and local recurrence after breast-conserving surgery. Arch Surg. 1994;129:952-956.
26. Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol. 1994;12:653-660.
27. Anscher M, Jones P, Prosnitz L, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 1993;218:22-28.
28. Smitt M, Nowels K, Zdeblick M, et al. The importance of the lumpectomy surgical margin status in long-terms results of breast conservation. Cancer. 1995;76:259-267.
29. Chen A, Meric-Bernstam F, Hunt K, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol. 2004;22:2303-2312.
30. Hanna W, Kahn H, Chapman J, et al. Pathologic characteristics of breast cancer that predict for local recurrence after lumpectomy alone. Breast J. 1999;5:105-111.
31. Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomized trial. Radiother Oncol. 1996;39:223-227.
32. Arriagada R, Le M, Contesso G, et al. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol. 2002;13:1404-1413.
33. Buccholz T, Tucker S, Erwin J, et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol. 2001;19:2240-2246.
34. Osteen R, Connolly J, Recht A, et al. Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg. 1987;122:1248-1252.
35. Schnitt S, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74:1746-1751.
36. Hurd T, Sneige N, Allen P, et al. Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy. Ann Surg Oncol. 1997;4:119-124.
37. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003;98:1802-1810.
38. Thurlimann B, Keshaviah A, Coates AS, et al. Breast International Group (BIG) 1-98 Collaborative Group: a comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med. 2005;353:2747-2757.